Articles liés à QUALITATIVE HEART-SPECIFIC FATTY ACID BINDING PROTEIN...

QUALITATIVE HEART-SPECIFIC FATTY ACID BINDING PROTEIN (H-FABP) TEST: CLINICAL EVALUATION IN MYOCARDIAL INFARCTION - Couverture souple

Nik Ab Rahman, Nik Hisamuddin; Suhailan, Ahmad

 
9783838387826: QUALITATIVE HEART-SPECIFIC FATTY ACID BINDING PROTEIN (H-FABP) TEST: CLINICAL EVALUATION IN MYOCARDIAL INFARCTION
Couverture souple
ISBN 10 : 3838387821 ISBN 13 : 9783838387826
Editeur : LAP LAMBERT Academic Publishing, 2010

Synopsis

Early and correct diagnosis of patients admitted to the hospital with symptoms suggestive of acute myocardial infarction (AMI) is paramount to ensure appropriate therapy is given to minimize myocardial injury and improve clinical outcome. The urgency in recognizing and treating patients with an AMI as early as possible has been repeatedly stressed and reiterated in various guidelines that lead to the well-known phrase of ?Time loss is myocardium loss'. As a consequence, the patient's prognosis will deteriorate.In situation like these, cardiac biomarkers may be invaluable in establishing a diagnosis of AMI in the ED setting. A number of established cardiac biomarkers have been available in the market and several new promising assays with better sensitivity have been discovered. A recent potential cardiac biomarker that shows release kinetics similar to myoglobin is heart-type fatty acid-binding protein (H-FABP). We believe that this diagnostic kit that detects H-FABP at the bedside, still needs further evaluation especially to assess its performance and practicality to detect AMI in patients presenting with chest pain in the ED setting.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

Early and correct diagnosis of patients admitted to the hospital with symptoms suggestive of acute myocardial infarction (AMI) is paramount to ensure appropriate therapy is given to minimize myocardial injury and improve clinical outcome. The urgency in recognizing and treating patients with an AMI as early as possible has been repeatedly stressed and reiterated in various guidelines that lead to the well-known phrase of ?Time loss is myocardium loss'. As a consequence, the patient's prognosis will deteriorate.In situation like these, cardiac biomarkers may be invaluable in establishing a diagnosis of AMI in the ED setting. A number of established cardiac biomarkers have been available in the market and several new promising assays with better sensitivity have been discovered. A recent potential cardiac biomarker that shows release kinetics similar to myoglobin is heart-type fatty acid-binding protein (H-FABP). We believe that this diagnostic kit that detects H-FABP at the bedside, still needs further evaluation especially to assess its performance and practicality to detect AMI in patients presenting with chest pain in the ED setting.

Biographie de l'auteur

Associate Professor Dr Nik Hisamuddin Nik Ab Rahman, MBChB, MMed, ACEP. Obtained his basic medical degree from the University of Glasgow. Current position include the head and consultant Emergency Medicine in the University Sains Malaysia. Main interests include trauma and injury prevention, resuscitation and acute pain management.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2010
Langue
anglais
ISBN 10 
3838387821
ISBN 13 
9783838387826
Reliure
Broché
Nombre de pages
152
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne